Innventure, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| June 30, 2025 (Unaudited) | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $6,965 | $11,119 |
| Accounts receivable, net | 901 | 283 |
| Due from related parties | 4,188 | 4,536 |
| Inventories, net | 6,620 | 5,178 |
| Prepaid expenses and other current assets | 2,455 | 3,170 |
| Total Current Assets | 21,129 | 24,286 |
| Restricted cash | 5,000 | — |
| Investments | 32,424 | 28,734 |
| Property, plant and equipment, net | 1,972 | 1,414 |
| Intangible assets, net | 171,345 | 182,153 |
| Goodwill | 323,463 | 667,936 |
| Other assets | 652 | 766 |
| Total Assets | $555,985 | $905,289 |
| Liabilities and Stockholders' Deficit | ||
| Accounts payable | $3,710 | $3,248 |
| Accrued employee benefits | 10,603 | 9,273 |
| Accrued expenses | 2,594 | 2,478 |
| Contract liabilities | 690 | — |
| Related party notes payable - current | — | 14,000 |
| Notes payable - current | 27,502 | 625 |
| Embedded derivative liability | 1,796 | — |
| Patent installment payable - current | 700 | 1,225 |
| Obligation to issue equity | 52 | 4,158 |
| Warrant liability | 22,996 | 34,023 |
| Income taxes payable | 292 | — |
| Related party convertible promissory notes - current | 1,002 | — |
| Other current liabilities | 380 | 317 |
| Total Current Liabilities | 72,317 | 69,347 |
| Notes payable, net of current portion | 11,304 | 13,654 |
| Term convertible notes, net of current portion | 2,451 | — |
| Related party convertible promissory notes, net of current portion | 3,000 | — |
| Earnout liability | 4,370 | 14,752 |
| Stock-based compensation liability | 474 | 1,160 |
| Patent installment payable, net of current portion | 12,375 | 12,375 |
| Deferred income taxes | 23,458 | 27,353 |
| Other liabilities | 176 | 355 |
| Total Liabilities | 129,925 | 138,996 |
| Commitments and Contingencies (Note 16) | ||
| Stockholders' Equity | ||
| Preferred stock, $0.0001 par value, 25,000,000 shares authorized; | ||
| Series B Preferred Stock, $0.0001 par value, 3,000,000 shares designated, 33,144 and 1,102,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | — | — |
| Series C Preferred Stock, $0.0001 par value, 5,000,000 shares designated, 150,000 and — shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | — | — |
| Common Stock, $0.0001 par value, 250,000,000 shares authorized, 55,221,494 and 44,597,154 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 6 | 4 |
| Additional paid-in capital | 525,346 | 502,865 |
| Accumulated other comprehensive (loss) gain | (1,289) | 909 |
| Accumulated deficit | (305,512) | (78,262) |
| Total Innventure, Inc., Stockholders’ Equity | 218,551 | 425,516 |
| Non-controlling interest | 207,509 | 340,777 |
| Total Stockholders' Equity | 426,060 | 766,293 |
| Total Liabilities and Stockholders' Equity | $555,985 | $905,289 |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
| Three months ended · Six months ended | |||||
|---|---|---|---|---|---|
| June 30, 2025 (Successor) · June 30, 2024 (Predecessor) · June 30, 2025 (Successor) · June 30, 2024 (Predecessor) | |||||
| Revenue | $476 | $223 | $700 | $447 | |
| Operating Expenses | |||||
| Cost of sales | 2,861 | — | 3,045 | — | |
| General and administrative | 18,569 | 8,379 | 38,245 | 16,283 | |
| Sales and marketing | 2,208 | 1,366 | 4,304 | 2,549 | |
| Research and development | 6,068 | 1,764 | 12,321 | 3,433 | |
| Goodwill impairment | 113,344 | — | 346,557 | — | |
| Total Operating Expenses | 143,050 | 11,509 | 404,472 | 22,265 | |
| Loss from Operations | (142,574) | (11,286) | (403,772) | (21,818) | |
| Non-operating (Expense) and Income | |||||
| Interest expense, net | (2,647) | (43) | (4,185) | (448) | |
| Net gain (loss) on investments | — | (790) | — | 4,399 | |
| Net gain (loss) on investments – due to related parties | — | 26 | — | (160) | |
| Change in fair value of financial liabilities | 7,176 | — | 23,605 | (478) | |
| Equity method investment (loss) income | (1,924) | 779 | (8,680) | 784 | |
| Realized gain on conversion of available for sale investment | — | — | 1,507 | — | |
| Loss on extinguishment of debt | (3,462) | — | (3,462) | — | |
| Loss on extinguishment of related party debt | — | — | (3,538) | — | |
| Loss on conversion of promissory notes | — | — | — | (1,119) | |
| Miscellaneous other expense | (64) | — | (43) | — | |
| Total Non-operating (Expense) Income | (921) | (28) | 5,204 | 2,978 | |
| Loss before income taxes | (143,495) | (11,314) | (398,568) | (18,840) | |
| Income tax benefit | (2,220) | — | (3,619) | — | |
| Net Loss | (141,275) | (11,314) | (394,949) | (18,840) | |
| Less: net loss attributable to | |||||
| Non-redeemable non-controlling interest | (57,048) | (4,026) | (167,725) | (6,333) | |
| Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (84,227) | (7,288) | (227,224) | (12,507) | |
| Basic and diluted loss per share | $(1.60) | $(4.60) | |||
| Basic and diluted weighted average common shares | 52,546,491 | 49,417,092 | |||
| Other comprehensive income, net of taxes: | |||||
| Unrealized gain (loss) on available for sale debt securities - related party | 189 | — | (691) | — | |
| Reclassification of realized gain on conversion of available for sale investments | — | — | (1,507) | — | |
| Total other comprehensive income, net of taxes | 189 | — | (2,198) | — | |
| Total comprehensive loss, net of taxes | (141,086) | (11,314) | (397,147) | (18,840) | |
| Less: comprehensive loss attributable to | |||||
| Non-redeemable non-controlling interest | (57,048) | (4,026) | (167,725) | (6,333) | |
| Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | $(84,038) | $(7,288) | $(229,422) | $(12,507) | |
Condensed Consolidated Statements of Changes in Unitholders' Deficit (Predecessor)
| Class B Preferred | Class B-1 Preferred | Class A | Class C | Accumulated Deficit | Non-Controlling Interest | Total (Deficit) Equity | |
|---|---|---|---|---|---|---|---|
| December 31, 2023 | $38,122 | $3,323 | $1,950 | $844 | $(64,284) | $1,559 | $(18,486) |
| Net loss | — | — | — | — | (5,219) | (2,307) | (7,526) |
| Units issued to non-controlling interest | — | — | — | — | — | 3,503 | 3,503 |
| Issuance of preferred units, net of issuance costs | 7,566 | — | — | — | — | — | 7,566 |
| Unit-based compensation | — | — | — | 51 | — | 345 | 396 |
| Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | — | — | — | — | 8,443 | 8,443 |
| Accretion of redeemable units to redemption value | — | — | — | — | (4,415) | — | (4,415) |
| March 31, 2024 | $45,688 | $3,323 | $1,950 | $895 | $(73,918) | $11,543 | $(10,519) |
| Net loss | — | — | — | — | (7,288) | (4,026) | (11,314) |
| Units issued to non-controlling interest | — | — | — | — | — | 7,348 | 7,348 |
| Issuance of preferred units, net of issuance costs | 2,852 | — | — | — | — | — | 2,852 |
| Unit-based compensation | — | — | — | 45 | — | 248 | 293 |
| Accretion of redeemable units to redemption value | — | — | — | — | (362) | — | (362) |
| June 30, 2024 | $48,540 | $3,323 | $1,950 | $940 | $(81,568) | $15,113 | $(11,702) |
Condensed Consolidated Statements of Changes in Mezzanine and Stockholders' Equity (Deficit) (Successor)
| Stockholders’ Equity · Mezzanine Equity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock · Series C Preferred Stock · Common Stock · Preferred Stock | |||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Additional Paid-In Capital | Accumulated Deficit | Accumulated OCI | Non-Controlling Interest | Total Stockholders' Equity | Shares | Amount | |
| December 31, 2024 | 1,102,000 | $— | — | $— | 44,597,154 | $4 | $502,865 | $(78,262) | $909 | $340,777 | $766,293 | — | $— |
| Net loss | — | — | — | — | — | — | — | (142,997) | — | (110,677) | (253,674) | — | — |
| Series B Preferred Stock buyback | (5,000) | — | — | — | — | — | (50) | — | — | — | (50) | — | — |
| Series B Preferred Stock issued for paid-in-kind dividends | 21,808 | — | — | — | — | — | 218 | — | — | — | 218 | — | — |
| Issuance of common shares, net of issuance costs | — | — | — | — | 161,964 | — | 1,927 | — | — | — | 1,927 | — | — |
| Vesting of earnout shares | — | — | — | — | 2,344,682 | 1 | 873 | — | — | — | 874 | — | — |
| Other comprehensive gain, net of taxes | — | — | — | — | — | — | — | — | (2,387) | — | (2,387) | — | — |
| Conversion of related party notes | — | — | — | — | — | — | — | — | — | — | — | 2,310,848 | 23,109 |
| Issuance of Series C Preferred Stock, net | — | — | — | — | — | — | — | — | — | — | — | 575,000 | 5,663 |
| Non-controlling interest issued and related transfers | — | — | — | — | — | — | (26,303) | — | — | 33,249 | 6,946 | — | — |
| Distributions to Stockholders | — | — | — | — | — | — | — | (26) | — | — | (26) | — | — |
| Stock-based compensation | — | — | — | — | — | — | 4,943 | — | — | 898 | 5,841 | — | — |
| Accrued preferred dividends | — | — | — | — | — | — | (217) | — | — | — | (217) | — | (44) |
| March 31, 2025 | 1,118,808 | $— | — | $— | 47,103,800 | $5 | $484,256 | $(221,285) | $(1,478) | $264,247 | $525,745 | 2,885,848 | $28,728 |
| Net loss | — | — | — | — | — | — | — | (84,227) | — | (57,048) | (141,275) | — | — |
| Issuance of common shares, net of issuance costs | — | — | — | — | 481,325 | — | 2,625 | — | — | — | 2,625 | — | — |
| Other comprehensive gain, net of taxes | — | — | — | — | — | — | — | — | 189 | — | 189 | — | — |
| Non-controlling interest issued and related transfers | — | — | — | — | — | — | 1,036 | — | — | (602) | 434 | — | — |
| Stock-based compensation | — | — | — | — | — | — | 8,494 | — | — | 912 | 9,406 | — | — |
| Accrued preferred dividends | — | — | — | — | — | — | 198 | — | — | — | 198 | — | 12 |
| Conversion to Common Stock | (1,085,664) | — | — | — | 7,636,369 | 1 | 27,269 | — | — | — | 27,270 | (2,735,848) | (27,272) |
| Transfer of Series C Preferred Stock from Mezzanine equity to Stockholders' equity | — | — | 150,000 | — | — | — | 1,468 | — | — | — | 1,468 | (150,000) | (1,468) |
| June 30, 2025 | 33,144 | $— | 150,000 | $— | 55,221,494 | $6 | $525,346 | $(305,512) | $(1,289) | $207,509 | $426,060 | $— | $— |
Condensed Consolidated Statements of Cash Flows
| Successor | Predecessor | |
|---|---|---|
| Six months ended June 30, 2025 | Six months ended June 30, 2024 | |
| Cash Flows Used in Operating Activities | ||
| Net loss | $(394,949) | $(18,840) |
| Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | ||
| Stock-based compensation | 15,247 | 689 |
| Interest income on debt securities - related party | (195) | — |
| Change in fair value of financial liabilities | (23,605) | 478 |
| Change in fair value of payables due to related parties | — | 160 |
| Non-cash interest expense on notes payable | 2,560 | 352 |
| Net gain on investments | — | (4,399) |
| Equity method investment gain (loss) | 8,680 | (784) |
| Realized gain on conversion of available for sale investments | (1,507) | — |
| Loss on extinguishment of debt | 3,462 | — |
| Loss on extinguishment of related party debt | 3,538 | — |
| Loss on conversion of promissory notes | — | 1,119 |
| Deferred income taxes | (3,897) | — |
| Depreciation and amortization | 11,182 | 69 |
| Goodwill impairment | 346,557 | — |
| Payment of patent installment | (525) | — |
| Other costs | 165 | 123 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (618) | — |
| Prepaid expenses and other current assets | (3,312) | (965) |
| Inventory | (1,442) | (662) |
| Accounts payable | 315 | 3,181 |
| Accrued employee benefits | 1,330 | 2,803 |
| Accrued expenses | 42 | 357 |
| Stock-based compensation liability | (686) | — |
| Income taxes payable | 292 | — |
| Other current liabilities | (78) | (72) |
| Contract liabilities | 690 | — |
| Net Cash Used in Operating Activities | (36,754) | (16,391) |
| Cash Flows Used in Investing Activities | ||
| Investment in available-for-sale debt securities - equity method investee | (2,708) | — |
| Loans to equity method investee | — | (5,035) |
| Acquisition of property, plant and equipment | (932) | (706) |
| Proceeds from sale of investments | — | 1,364 |
| Net Cash Used in Investing Activities | (3,640) | (4,377) |
| Cash Flows Provided by Financing Activities | ||
| Proceeds from issuance of equity, net of issuance costs | 3,675 | 10,037 |
| Proceeds from the issuance of equity to non-controlling interest, net of issuance costs | 5,367 | 10,827 |
| Proceeds from the issuance of related party convertible promissory notes | 3,999 | — |
| Proceeds from the issuance of term convertible notes | 2,451 | — |
| Proceeds from issuance of debt securities, net of issuance costs | 27,000 | — |
| Payment of debts | (1,176) | (590) |
| Distributions to stockholders and other | (76) | — |
| Net Cash Flows Provided by Financing Activities | 41,240 | 20,274 |
| Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash | 846 | (494) |
| Cash, Cash Equivalents and Restricted Cash Beginning of period | 11,119 | 2,575 |
| Cash, Cash Equivalents and Restricted Cash End of period | $11,965 | $2,081 |
Condensed Consolidated Statements of Cash Flows
| Successor | Predecessor | |
|---|---|---|
| Six months ended June 30, 2025 | Six months ended June 30, 2024 | |
| Supplemental Cash Flow Information | ||
| Cash paid for interest | $1,825 | $99 |
| Supplemental Disclosure of Noncash Financing Information | ||
| Accretion of redeemable units to redemption value | — | 4,777 |
| Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | 7,324 |
| Conversion of working capital loans to equity method investee into investments in debt securities - related party | 4,375 | — |
| Extinguishment of debt with Series C Preferred Stock | 14,000 | — |
| Contribution of Series C Preferred Stock to equity method investee | 5,783 | — |
| Conversion of AFX available-for-sale term loan into equity method investments | 8,757 | — |
| Issuance of common stock as repayment of convertible debt | 2,533 | — |
| Issuance of stock in exchange for services | 4,095 | — |
| Conversion of preferred stock into common stock | 36,910 | — |
| Transfer of Series C Preferred Stock from Mezzanine to Stockholders' equity | 1,468 | — |
| Embedded derivative in association with Convertible Debentures | 1,774 | — |
| Equity reallocation between non-controlling interest and additional paid-in capital | 25,268 | — |
Note 1. Nature of Business
Unless the context otherwise requires, references herein to "Innventure", "we", "us", "our" and "the Company" refer to the business and operations of Innventure LLC and its consolidated subsidiaries (the “Predecessor”) for all periods prior to the Closing (as defined below) and to the business and operations of Innventure, Inc., and its consolidated subsidiaries (the “Successor”) for all periods after Closing. All balance sheet amounts presented are for Successor periods.
Innventure founds, funds, and operates companies with a focus on transformative, sustainable technology solutions that we acquire or license from technology innovators, which are typically MNCs. As owner-operators, our goal is to take what we believe to be breakthrough technologies from evaluation to scaled commercialization utilizing an approach designed to help mitigate risk in collaboration with the MNCs (our channel partner(s)), as we build disruptive companies that we believe have the potential to achieve a target enterprise value of at least $1 billion. We define ‘‘disruptive’’ as innovations that, in our opinion, have the ability to significantly change the way businesses, industries, markets, and/or consumers operate. Innventure, Inc., is headquartered in Orlando, Florida.
Business Combination
As further discussed in our 2024 Annual Report, on October 2, 2024 (the “Closing Date” or “Closing”), Learn CW Investment Corporation (“Learn CW”), a Cayman Islands exempted company, and Innventure LLC, a Delaware limited liability company, consummated a business combination (the “Business Combination”) pursuant to the terms of the Business Combination Agreement previously entered into on October 24, 2023. Following the Closing, both Learn CW and Innventure LLC became subsidiaries of Learn SPAC HoldCo, Inc. (“Holdco”), a Delaware corporation and direct, wholly-owned subsidiary of Learn CW prior to Closing. Holdco changed its name to “Innventure, Inc.” and became a publicly traded company. Holdco was determined to be the accounting acquirer. Innventure, Inc., and its subsidiaries are the successor to Innventure LLC following the Business Combination.
The information provided in this Quarterly Report on Form 10-Q reflects two distinct periods, the period up to the Closing Date labeled as the Predecessor and the period including and after that date labeled as the Successor. The Business Combination was accounted for using the acquisition method of accounting and the Successor financial statements reflect a new basis of accounting that is based on the fair value of the net assets acquired. As a result of the application of the acquisition method of accounting as of the Closing Date, the accompanying condensed consolidated financial statements include a black line division which indicates that the Predecessor and Successor reporting entities shown are presented on a different basis and are therefore, not comparable.
Note 2. Accounting Policies
Basis of Presentation
These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company's most recent annual audited consolidated financial statements and notes thereto. These condensed consolidated financial statements have been prepared in accordance with the instructions for the Securities and Exchange Commission’s (“SEC’s”) Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to rules and regulations of the SEC, although the Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments, consisting only of normal recurring adjustments considered necessary for a fair presentation of results of operations and financial position, have been included.
We use the same accounting policies in preparing quarterly and annual financial statements.
During the six months ended June 30, 2025 (Successor), we identified an error and recorded an immaterial out of period adjustment of $12,448 to correct an overstatement of Additional paid-in capital, an immaterial out of period adjustment of $4,468 to correct understatement of Net loss attributable to Innventure, Inc. stockholders and an immaterial out of period adjustment of $16,915 to correct an understatement of Non-controlling interest. The impact of the adjustments are not material to the condensed consolidated financial statements for any interim or annual periods prior to June 30, 2025 nor the current financial period. The out of period adjustment to Additional paid-in capital is included in the Non-controlling interest issued and related transfers within the condensed consolidated statements of changes in mezzanine and stockholders' equity (deficit) and the adjustment related to Net loss attributable to Innventure, Inc. within Comprehensive loss attributable to Non-redeemable non-controlling interest on the condensed consolidated statements of operations and comprehensive income (loss).
Reclassifications
Certain amounts reported previously have been reclassified to conform to the current year presentation with no effect on total stockholders' deficit, or net loss as previously reported.
Going Concern
As of June 30, 2025, the Company had cash balance of $6,965, a restricted cash balance of $5,000, accumulated deficit of $305,512 and a working capital deficit of $51,188. During the three and six months ended June 30, 2025 (Successor), the Company incurred a net loss of $141,275 and $394,949, respectively. We have experienced recurring losses from operations and negative cash flows from operating activities. In addition, we continue to have an ongoing need to raise significant additional cash from outside sources to sustain our operations and fund our growth plans.
In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern within one year after the date of the condensed consolidated financial statements included in Item 1. of this Form 10-Q. If we are unable to obtain adequate capital from public or private equity or debt financing (including the SEPA), or otherwise generate sufficient revenues from our Operating Companies to support our cost structure within the normal operating cycle of a twelve (12) month period, we may have to implement cost reduction measures or adjust the timing or scope of certain operations at Innventure or certain Innventure Companies, in part or in full, to help manage liquidity. If we raise additional funds through the issuance of additional debt or equity securities, it could result in substantial dilution to our existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of our common stock, $0.0001 par value per share (“Common Stock”). See “Item 1A. Risk Factors – Risks Related to Innventure’s Business – There is uncertainty regarding Innventure’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt about its ability to continue as a going concern.” in our 2024 Annual Report.
We can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to us, if at all. If subsequent capital raises or revenues from operations at the Innventure Companies are insufficient to bridge financial and liquidity shortfalls (or both), there would likely be a material adverse effect on our business and financial condition that would materially adversely affect our ability to continue as a going concern.
The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date of the accompanying condensed consolidated financial statements are issued; however, the above conditions raise substantial doubt about the Company’s ability to do so. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. There can be no assurance that management will be successful in implementing its business plan or that the successful implementation of such business plan will improve our operating results.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"), which enhances prior reportable segment disclosure requirements in part by requiring entities to disclose significant expenses related to their reportable segments. The amendments in ASU 2023-07 are effective on a retrospective basis for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company has made the required disclosures related to this ASU within Note 17. Business Segment Data.
Recently Issued But Not Yet Adopted Accounting Standards
In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative(“ASU 2023-06”). This standard modifies the disclosure or presentation requirements of a variety of topics and aligns requirements with the SEC’s existing disclosure requirements. ASU 2023-06 is effective on the date each amendment is removed from Regulation S-X or Regulation S-K with early adoption prohibited. The Company will monitor the removal of various requirements from the current regulations in order to determine when to adopt the related amendments but does not anticipate the adoption of the new guidance will have a material impact on the Company’s condensed consolidated financial statements. The Company will continue to evaluate the impact of this guidance on its condensed consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid to enhance the transparency and decision usefulness of income tax disclosures. The amendments in this ASU are effective for annual periods beginning after December 15, 2024 on a prospective basis. The Company is currently evaluating the impact that the adoption of this accounting standard will have on its condensed consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses("ASU 2024-03"). In January 2025, the FASB issued Clarifying the Effective Date (“ASU 2025-01”) to add some clarity around the effective date of the guidance. ASU 2024-03 requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The new standard is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively, to financial statements issued after the effective date, or retrospectively, to all prior periods presented. The Company is currently evaluating the impact that the adoption of this accounting standard will have on its condensed consolidated financial statements.
In May 2025, the FASB issued ASU 2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer, which reduces the diversity in practice and improves the decision usefulness and operability of the guidance for share-based consideration payable to a customer in conjunction with selling goods or services. The amendments in this ASU are effective for annual reporting periods (including interim reporting periods within annual reporting periods) beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this accounting standard will have on its condensed consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for the application of the current expected credit loss (“CECL”) model to current accounts receivable and contract assets. The amendments in this ASU are effective for the fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. If elected, the amendments in this ASU should be applied prospectively. The Company is currently evaluating the impact ASU 2025-05 will have on its condensed consolidated financial statements.
Note 3. Investments
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Equity-method investments | $23,407 | $17,547 |
| Investment in debt securities - AFS | 9,017 | 11,187 |
| Total Investments | $32,424 | $28,734 |
Equity-method investments
ESG Fund
The Innventus ESG Fund I, L.P. (the “ESG Fund”) is an investment company that follows a specialized basis of accounting established by GAAP. The Company’s general partnership interest in the ESG Fund is substantially illiquid. While the ESG Fund’s holdings are accounted for at fair value, the equity-method investment in the ESG Fund is adjusted to reflect the fair value of the underlying investments of the ESG Fund as of June 30, 2025 and December 31, 2024. The fair value of the underlying investments in the ESG Fund is based on the Company’s assessment, which takes into account expected cash flows, earnings multiples and/or comparisons to similar market transactions, among other factors. Valuation adjustments reflecting consideration of credit quality, concentration risk, sales restrictions and other liquidity factors are integral to valuing these instruments.
AeroFlexx
The Company held a 37% and 34% equity method investment interest in AeroFlexx as of June 30, 2025 and December 31, 2024, respectively.
Investment in debt securities - Available for Sale (“AFS”)
On July 1, 2024, the Company entered into a loan agreement with AeroFlexx under which the Company will lend up to $10,000 to AeroFlexx.
The term loans and any unpaid accrued interest are required to be repaid by the maturity date, which is the earlier of (i) December 31, 2026 or (ii) the date of the sale, transfer or other disposition of all AeroFlexx’s assets or AeroFlexx's stock. After any full or partial repayment of the term loans, AeroFlexx may borrow additional funds up to the $10,000 limit until the maturity date. The loans bear interest at the applicable federal rate published by the Internal Revenue Service and is adjusted on a quarterly basis.
The Company has an option to convert the outstanding principal amount of the term loans and any unpaid accrued interest into shares or units in connection with the next issuance of equity securities by AeroFlexx, at a price equal to 100% of the price per share or unit and on the same terms and conditions as applicable to such issuance.
During 2024, the Company lent AeroFlexx the entire $10,000 principal balance under this agreement. As of January 1, 2025, AeroFlexx was unable to raise any additional equity financing; therefore, the outstanding principal and unpaid accrued interest with an amount equal to the equity deficit of $7,250 was automatically converted into Class D preferred units of AeroFlexx at the price of $6.83 per share in accordance with the loan agreement. Upon conversion, a realized gain of $1,507 was recognized for the six months ended June 30, 2025 (Successor) and is included in non-operating income in the condensed consolidated statements of operations and comprehensive income (loss).
During the three months ended June 30, 2025 (Successor), $371 was drawn down by AeroFlexx under the term loan. During the six months ended June 30, 2025 (Successor), $4,375 was reclassified from Due from related parties under the term loan and $2,708 was drawn down by AeroFlexx under the term loan. The total balance drawn as of June 30, 2025 was $10,000.
The Company accounted for the loans as an investment in debt securities and classified them as available for sale debt securities. Based on the AFS classification, the Company records this investment at fair value at each reporting date and as such recorded the changes in fair value of these loans (including the adjustment to fair value at inception date) in Other comprehensive income ("OCI").
As the contractual maturity of the loan is December 31, 2026, it is included in the non-current line item Investments of the condensed consolidated balance sheets. The increase of $189 and decrease of $691 in fair value of this investment in debt securities for the three and six months ended June 30, 2025 (Successor), respectively, is included as Unrealized gain (loss) on available for sale debt securities - related party in the condensed consolidated statements of operations and comprehensive income (loss).
Additionally, the Company’s carrying amount and maximum exposure relating to AeroFlexx advances and other receivables were $3,897 and $4,472 as of June 30, 2025 and December 31, 2024, included in Due from related parties on the condensed consolidated balance sheets.
Note 4. Fair Value
The following tables present the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024:
| June 30, 2025 | Quoted Pricesin ActiveMarkets forIdentical Assets(Level 1) | Significant OtherObservable Inputs(Level 2) | SignificantUnobservableInputs(Level 3) | Total |
|---|---|---|---|---|
| Assets: | ||||
| Investment in debt security - AFS | $— | $— | $9,017 | $9,017 |
| Liabilities: | ||||
| Earnout liability | $— | $— | $4,370 | $4,370 |
| 2024 WTI Warrant liability | — | — | 12,450 | 12,450 |
| 2025 WTI Warrant liability | — | — | 3,400 | 3,400 |
| Private placement warrant liability | — | 7,146 | — | 7,146 |
| Embedded derivative liability - Convertible Debentures | — | — | 1,796 | 1,796 |
| December 31, 2024 | Quoted Prices in Active Markets for Identical Assets(Level 1) | Significant Other Observable Inputs(Level 2) | Significant Unobservable Inputs(Level 3) | Total |
|---|---|---|---|---|
| Assets: | ||||
| Investment in debt security - AFS | $— | $— | $11,187 | $11,187 |
| Liabilities: | ||||
| Earnout liability | $— | $— | $14,752 | $14,752 |
| 2024 WTI Warrant liability | — | — | 17,230 | 17,230 |
| Private placement warrant liability | — | 16,793 | — | 16,793 |
Gains and losses for such assets and liabilities categorized within the Level 3 table set forth may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
Changes in the estimated fair value of Level 3 financial assets and liabilities that are measured on a recurring basis for the six months ended June 30, 2025 (Successor) and the six months ended June 30, 2024 (Predecessor), respectively, are as follows:
| Embedded derivative liability - convertible promissory notes | Investment in debt securities - AFS | Earnout liability | 2024 WTI Warrant liability | 2025 WTI Warrant liability | Embedded derivative liability - Convertible Debentures | |
|---|---|---|---|---|---|---|
| Balance as of January 1, 2024 (Predecessor) | $1,994 | $— | $— | $— | $— | $— |
| Settlement | (2,472) | — | — | — | — | — |
| Change in fair value | 478 | — | — | — | — | — |
| Balance as of June 30, 2024 (Predecessor) | $— | $— | $— | $— | $— | $— |
| Balance as of January 1, 2025 (Successor) | $— | $11,187 | $14,752 | $17,230 | $— | $— |
| Additions | — | 7,278 | — | — | 3,090 | 1,774 |
| Settlement | — | (8,757) | (873) | — | — | — |
| Change in fair value | — | (691) | (9,509) | (4,780) | 310 | 22 |
| Balance as of June 30, 2025 (Successor) | $— | $9,017 | $4,370 | $12,450 | $3,400 | $1,796 |
There were no transfers in or out of levels during the three and six months ended June 30, 2025 (Successor) nor for the three and six months ended June 30, 2024 (Predecessor).
The following table summarizes the significant unobservable inputs (Level 3):
| Principal ValuationTechniques · UnobservableInputs · June 30, 2025 · December 31, 2024 | ||||
|---|---|---|---|---|
| Investment in debt securities - AFS: | ||||
| Black-Scholes model | Volatility | 120% | ||
| Time to liquidity · 2 years | ||||
| Discount for lack of marketability | 31.00% | |||
| Weighted average cost of capital | 45.00% | |||
| Risk-free rate | 4.23% | |||
| Discounted Cash Flows | AeroFlexx yield | 13.31% | ||
| Earnout Shares: | ||||
| Geometric Brownian Motion · Term · 6.3 years · 6.8 years | ||||
| Stock price | $4.80 | $13.85 | ||
| Volatility | 56.00% | 56.00% | ||
| Risk-free rate | 3.87% | 4.42% | ||
| Revenue risk premium | 28.20% | 36.10% | ||
| Revenue volatility | 152.00% | 176.00% | ||
| 2024 WTI Warrants: | ||||
| Geometric Brownian Motion | Stock price | $4.80 | $13.85 | |
| Stock price volatility | 56.00% | 56.00% | ||
| Credit spread | 25.60% | 18.80% | ||
| 2025 WTI Warrants: | ||||
| Geometric Brownian Motion | Stock price | $4.80 | ||
| Stock price volatility | 56.00% | |||
| Credit spread | 25.60% | |||
| Embedded derivative liability - Convertible Debentures: | ||||
| Discounted Cash Flows | Debt Yield | 40.60% | ||
As further discussed and defined in Note 5. Borrowings, the Company issued Convertible Debentures (as defined below) which contain certain features which qualify as embedded derivates requiring bifurcation. The fair value of the embedded derivative liability is determined utilizing a “with and without” method, in which the fair value is calculated as the difference in the fair value of the entire hybrid instrument and the fair value of the instrument excluding the bifurcated derivative features. The initial fair value of the embedded derivative was determined using a discounted cash flow model as of April 14, 2025 and May 15, 2025 which is reflective of the dates of the Convertible Debenture issuances. The model uses a significant assumption of a debt yield of 44.5% for the April 14, 2025 issuance and 42.6% for the May 15, 2025 issuance.
As further discussed in Note 3. Investments, outstanding principal and accrued interest of $7,250 for the investment in debt securities - AFS was automatically converted into Class D preferred units in accordance with the loan agreement. Prior to the conversion, the fair value was estimated using a Black Scholes model. Post conversion, the fair value is estimated using a discounted cash flow model by discounting the contractual debt cash flows at a rate incorporating the credit risk of AeroFlexx.
The initial fair value of the 2025 WTI Warrants (as defined and further described below) was determined using a Monte Carlo valuation model in which the future stock price is simulated assuming a Geometric Brownian Motion in a risk-neutral framework. The model utilizes significant assumptions including stock price, stock price volatility and credit spread. Specifically, the initial valuation as of the April 14, 2025 issuance date considered a stock price of
$3.65, stock price volatility of 57.00%, and credit spread of 27.70%. The credit spread relates to estimated counterparty credit risk of Innventure being able to make payments related to the WTI Lenders’ put right, in which the WTI Lenders may exchange the 2025 WTI Warrants for a total cash payment of $3,000 after the 10-year anniversary of issuance. The risk-free interest rate was determined by reference to the U.S. Treasury yield curve.
For further information on the Earnout Shares (as defined below), 2024 WTI Warrants (as defined below), and 2025 WTI Warrants, refer to Note 9. Earnout Shares and Note 10. Warrants.
Note 5. Borrowings
| Maturities | June 30, 2025 | Interest Rates | December 31, 2024 | Interest Rates | |
|---|---|---|---|---|---|
| Series 1 promissory notes | 2025 - 2026 | $425 | 15% | $725 | 12% - 15% |
| Related party notes | — | — | — | 14,000 | 8% - 15.99% |
| Convertible debentures | 2026 | 28,172 | —% | — | |
| Term convertible notes | 2026 | 2,451 | 3.94% | — | |
| Related party convertible notes | 2025 - 2026 | 4,002 | 3.94% - 15% | — | |
| WTI Facility | 2028 | 20,000 | 13.50% | 20,000 | 13.50% |
| Total Notes Payable | 55,050 | 34,725 | |||
| Less: unamortized debt discount | (9,791) | (6,446) | |||
| Less: current portion of related party notes payable | — | (14,000) | |||
| Less: current portion of related party convertible notes | (1,002) | — | |||
| Less: current portion of notes payable | (27,502) | (625) | |||
| Total Long-term Notes | $16,755 | $13,654 |
The Company's debt is carried on a historical cost basis net of unamortized discounts and premiums. Costs associated with acquiring debt are presented in the condensed consolidated balance sheets as a direct deduction from the carrying amount of the debt as a debt discount. Discounts on debt are amortized over the contractual life of the related debt instrument using the effective interest method (unless otherwise specified below) and are included in Interest expense, net in the condensed consolidated statements of operations and comprehensive income (loss).
The Company’s notes payable, excluding debt issuance costs, mature as follows:
| Year Ending December 31, | Amount |
|---|---|
| 2025 (remaining 6 months) | $13,011 |
| 2026 | 29,234 |
| 2027 | 8,244 |
| 2028 | 4,561 |
| Total Debt | $55,050 |
Series 1 Promissory Notes
In 2018, the Company authorized the issuance and sale of unsecured promissory notes to investors up to $35,000 (the “Series 1 promissory notes”). From 2018 to 2021, the Company issued promissory notes with a total principal amount of $4,936. The notes require monthly interest payments, have an original maturity period of 36-48 months, and bear interest at 9%-12% per annum. The notes containtwo term extension options, at the Company’s election, which can extend the notes’ maturity period to 60 months in total. If the Company elects its first term extension option, the note will bear interest at 12% for months 36 through 48. If the Company elects its second term extension option, the notes will bear interest at 15% for months 48 through 60.
Extensions on Series 1 promissory notes were as follows:
| Three months ended · Six months ended | |||||
|---|---|---|---|---|---|
| Interest Rate | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Principal amount of 1st extension promissory notes | 12% | $— | $— | $— | $122 |
| Principal amount of 2nd extension promissory notes | 15% | $— | $— | $122 | $300 |
Interest expense on Series 1 promissory notes was as follows:
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Interest attributable to contractual interest | $16 | $44 | $48 | $99 |
Related Party Notes
The Company entered into unsecured promissory notes withtwo related parties, the first on August 20, 2024, for a principal amount of $10,000, and the second on August 22, 2024, for a principal amount of $2,000. The Company entered into amended and restated agreements to amend the terms of these unsecured promissory notes on October 1, 2024. As per the original agreements, the note with the first party contained a loan fee of $1,000 which was payable with the repayment of the principal amount of the note and the note with the second party contained interest at the rate of 11.50% per annum.
As per the amended note with the first party, the maturity date was extended to the earlier of (i) January 31, 2025 and (ii) the first business day following the date on which the Company has sufficient capital to be able to repay all amounts outstanding under the note and otherwise meet its expected working capital needs as determined by the Company in its reasonable discretion. The loan fee of $1,000, required under the original agreement, became due on or around the amendment date and interest will accrue at the rate of 15.99% per annum until paid. The amendment was accounted for as a troubled debt restructuring as the Company was provided a concession through a decrease in the effective interest rate. However, no gain or loss was recognized as a result.
As per the amended note with the second party, the maturity date was extended to January 31, 2025 and the interest rate was increased to 13.50% per annum. Additionally, $1,000 of the principal amount became due on or around the amendment date.
Interest expense on the related party notes was as follows:
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Total interest expense | $— | $— | $419 | $— |
In addition to the related party notes above, the Company also had a related party note for $1,000 through an unsecured promissory note with an additional related party dated May 2, 2024. As per the terms of the executed agreement, the principal amount became due on December 21, 2024 and interest will accrue at the rate of 8.00% per annum. Upon maturity, the Company is required to repay the outstanding principal amount of $1,000 and a loan fee equal to approximately $63.
On March 20, 2025, in connection with the issuance of Series C Preferred Stock (as defined below), the Company extinguished the outstanding amount of related party notes. The Company recognized a loss of $— and $3,538 in Loss on extinguishment of related party debt on the condensed consolidated statements of operations and comprehensive income (loss) for the three and six months ended June 30, 2025 (Successor), respectively.
WTI Facility
On October 22, 2024, the Company entered into a term loan with WTI Fund X, Inc. and WTI Fund XI, Inc., (collectively, “WTI Lenders”). The terms of the loan provides for a term loan facility in the aggregate principal amount of up to $50,000 (the "WTI Facility"). The total aggregate principal was available inthree separate tranches subject to the Company meeting certain conditions. The Company received $20,000 (the “First Tranche”) on November 15, 2024. The First Tranche, principal and interest, shall be repaid over a period of 30 months in equal, monthly installments, commencing after an initial 12-month period of interest-only monthly payments, resulting in a total term of 42 months. The interest rate on the outstanding principal amounts under the WTI Facility for the three and six months ended June 30, 2025 (Successor) was 13.50%.
Borrowings under the WTI Facility will accrue interest at a rate per annum equal to the greater of (i) the “prime rate” of interest, as published by The Wall Street Journal on the date that the WTI Lenders prepare the promissory notes for the borrowings under such tranche, plus 5% and (ii)13.50% and will amortize, after an interest-only period oftwelve months in the case of the First Tranche in equal monthly installments over a period ofthirty months. Obligations are secured by a lien on the majority of the assets of Innventure LLC and Innventure, Inc.
In connection with the WTI Facility, the Company issued the 2024 WTI Warrants to the WTI Lenders (as further defined and described in Note 10. Warrants). The Company accounted for each of the 2024 WTI Warrants as detachable warrants at their fair value. The fair value of the 2024 WTI Warrants was recorded as a liability and as a discount to the WTI Facility on the condensed consolidated balance sheets. The Company is amortizing the discount over the term of the WTI Facility using the straight-line method.
On March 21, 2025, in connection with the issuance of the first tranche of Convertible Debentures (as further described below) to Yorkville, the Company and Innventure LLC entered into a consent (the “Consent”) with WTI Fund X, LLC and WTI Fund XI, LLC (the “WTI Holders”) and the WTI Lenders, modifying the WTI Facility. Specifically, under the Consent, the Company and the WTI Lenders and WTI Holders agreed (i) that from and after the date that the Company receives the initial proceeds from the Convertible Debentures and until such time as such obligations have been paid in full, the Company must maintain at least $5,000 of cash on deposit; (ii) that effective on the date that the Company receives the initial proceeds from the Convertible Debentures, the 2025 WTI Warrants will become payable to the WTI Lenders and their affiliates; and (iii) to certain additional consent provisions. Such provisions from the Consent became effective on April 14, 2025 when the Company received proceeds from the Convertible Debentures. The modification of the WTI Facility was accounted for as an extinguishment of debt though the WTI Facility remains outstanding, resulting in a loss on extinguishment of $3,462 recorded on the condensed consolidated statements of operations and comprehensive income (loss) for the three and six months ended June 30, 2025 (Successor). The legal requirement to maintain at least $5,000 of cash on deposit is presented as Restricted cash on the condensed consolidated balance sheets.
Interest expense on this facility was as follows:
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Interest attributable to contractual interest | $683 | $— | $1,358 | $— |
| Interest attributable to amortization of issuance costs and discounts | 348 | — | 856 | — |
| Total interest expense | $1,031 | $— | $2,214 | $— |
Convertible Debentures
On March 25, 2025, the Company entered into a securities purchase agreement (“Securities Purchase Agreement”) with Yorkville related to the issuance and sale of convertible debentures (“Convertible Debentures”) with an aggregate principal amount of up to $30,000. These Convertible Debentures are convertible into shares of Common Stock (as converted, the “Conversion Shares”). The Convertible Debentures contain certain features which qualify as embedded derivatives requiring bifurcation. Therefore, the bifurcated features are accounted for separately as a compound embedded derivative and included within Embedded derivative liability on the condensed consolidated balance sheets. The host contract, which represents the Convertible Debentures excluding the embedded derivative liability is included in Notes payable - current on the condensed consolidated balance sheets. The Company issued the aggregate principal amount of Convertible Debentures intwo tranches tied to separate reporting and filing requirements.
On April 14, 2025, the Company issued the first tranche of the Convertible Debentures with a principal amount of $20,000 in accordance with the Securities Purchase Agreement. The first tranche resulted in gross proceeds to the Company of approximately $18,000, representing an original issue discount of 10% and is scheduled to be repaid intwelve monthly payments with a 5% payment premium due to the lender with each payment. Also on April 14, 2025, the Company issuedtwo warrants (the “2025 WTI Warrants”) to purchase, at a price of $0.01 per share (subject to certain limitations and adjustment), up to an aggregate total of 495,074 shares of Common Stock, as of the date of issuance and June 30, 2025 (subject to future adjustments to the number and type of shares pursuant to the 2025 WTI Warrants), to the WTI Holders. Each of the 2025 WTI Warrants is exercisable through March 31, 2035. For further information on the 2025 WTI Warrants, refer to Note 10. Warrants.
On May 15, 2025, the Company issued the second tranche of Convertible Debentures with a principal amount of $10,000 in accordance with the Securities Purchase Agreement. The second tranche resulted in gross proceeds to the Company of approximately $9,000, representing an original issue discount of 10% and is scheduled to be repaid ineleven monthly payments with a 5% payment premium due to the lender with each payment. There is no contractual interest associated with amounts outstanding for the Convertible Debentures for the three and six months ended June 30, 2025 (Successor).
On June 4, 2025, the Company entered into an amendment to the Securities Purchase Agreement. The amendment changed the share conversion price to the lessor of: a) $10.00 per share of Common Stock, subject to downward assessment on two reset dates (October 14, 2025, and January 14, 2026) or b) the greater of (i) the average volume-weighted average price (“VWAP”) for theten trading days prior to the two reset dates and (ii) $2.00, subject to adjustments for stock splits or combinations.
During the three and six months ended June 30, 2025 (Successor), the Company issued 473,825 shares of its Common Stock pursuant to the SEPA in payment of $2,335 of principal and $117 of payment premium of the Convertible Debentures. For further information on this conversion, see Note 11. Stockholders' Equity. During the three and six months ended June 30, 2025 (Successor), the Company made cash payments toward the outstanding loan balance totaling $834 of principal and $42 of payment premium.
Interest expense on this facility was as follows:
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Interest attributable to amortization of issuance costs | 1,701 | — | 1,701 | — |
| Total interest expense | $1,701 | $— | $1,701 | $— |
Term Convertible Notes
Accelsius entered into unsecured convertible notes with various other parties (the “Term Convertible Notes”) for a total principal amount of $7,750. As of June 30, 2025, $2,750 of agreements were executed and $2,450 of proceeds had been received. The Term Convertible Notes have a stated maturity date of December 31, 2026 and bear interest at the annual applicable federal rate published by the Internal Revenue Service.
The Term Convertible Notes, which are subordinated to the WTI Facility, are convertible at the option of the lenders, starting January 2, 2026, for all amounts due under the notes at the time of conversion, into Accelsius’ Series A Units at a price per unit equal to $12.175. For as long as any portion of the WTI Facility remains outstanding, the lenders will not demand payment related to this Term Convertible Notes, unless they convert the debt into equity.
The interest expense on the Term Convertible Notes was $1 for the three and six months ended June 30, 2025 (Successor).
Related Party Convertible Notes
On June 26, 2025, Accelsius entered into an unsecured Convertible Promissory Note (“CPN”) with a related party lender. The maximum principal amount under the CPN is $3,000, issuable inthree equal draws, upon the request of Accelsius and subject to the related party’s sole discretion. Accelsius received the first draw amounting to $1,000 on June 27, 2025. The CPN has a stated interest rate of 15% and Accelsius is required to pay a loan fee (“Loan Fee”) of $35 upon maturity, repayment or conversion of this note.
The CPN is convertible at the option of the related party lender for all amounts due under the Convertible Note, including the Loan Fee, into either preferred units of Accelsius at a price equal to 80% of the next funding round price if Accelsius raises at least $5,000 from unaffiliated investors, or into common units of Accelsius, if no such funding round occurs before the maturity date, with unit pricing of common units determined by an independent valuation firm.
The CPN has a maturity date of December 31, 2025; is subordinated to the WTI Facility and the Convertible Debentures; and each of the WTI Lenders and Yorkville have been granted certain rights under the CPN. The CPN related party lender will not demand payment of this note, for so long as any portion of the WTI Facility or Convertible Debentures remains outstanding. Furthermore, pursuant to a Side Letter, dated June 26, 2025, by and among the Company, Innventure LLC, Accelsius and the related party, until such time as the CPN is either repaid in full or converted into equity of Accelsius, the Company will not seek repayment of any portion of that certain Loan and Security Agreement between Innventure LLC and Accelsius, dated as of March 30, 2023 (subject to certain exceptions).
Accelsius also entered into unsecured convertible notes (“Related Party Term Convertible Notes”, together with the CPN, the “Related Party Convertible Notes”) with certain investors deemed to be Related Parties (as defined in the
Company’s Related Party Transactions Policy) for a total principal amount of $4,250. Proceeds of $3,000 from the Related Party Term Convertible Notes were received as of June 30, 2025. The Related Party Term Convertible Notes have a stated maturity date of December 31, 2026 and bear interest at the annual applicable federal rate published by the Internal Revenue Service.
The Related Party Term Convertible Notes, which are are subordinated to the WTI Facility, are convertible at the option of the lenders, starting January 2, 2026, for all amounts due under the notes at the time of conversion, into Accelsius’ Series A Units at a price per unit equal to $12.175. For as long as any portion of the WTI Facility remains outstanding, the Related Party Term Convertible Notes lenders will not demand payment related to the Related Party Term Convertible Notes, unless they convert the debt into equity.
The interest expense on Related Party Convertible Notes, including the amortization of the loan fee, was $3 for the three and six months ended June 30, 2025 (Successor).
Note 6. Inventories, net
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Raw materials | $3,560 | $2,974 |
| Work in process | 26 | 50 |
| Finished goods | 3,034 | 2,154 |
| Total inventories | $6,620 | $5,178 |
Note 7. Property, Plant and Equipment
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Leasehold improvements | $887 | $548 |
| Machinery & equipment | 1,524 | 664 |
| Computers & office equipment | 14 | 14 |
| Construction in progress | — | 266 |
| Property, plant and equipment, gross | 2,425 | 1,492 |
| Less: Accumulated depreciation | (453) | (78) |
| Property, plant and equipment, net | $1,972 | $1,414 |
Note 8. Goodwill and Intangible Assets
Goodwill
| Balance as of December 31, 2024 | $667,936 |
|---|---|
| Impairment | (346,557) |
| Other | 2,084 |
| Balance as of June 30, 2025 | $323,463 |
In addition to annual impairment testing of goodwill, which is performed in the fourth quarter of each fiscal year, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore would require interim impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization and general industry, market and macroeconomic conditions. During the three and six months ended June 30, 2025 (Successor), the Company recorded $113,344 and $346,557 non-deductible, non-cash goodwill impairment charges, respectively, within the condensed consolidated statements of operations and comprehensive income (loss) due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market in late February 2025 through April 2025. The Company’s stock price had not yet recovered as of June 30, 2025.
The Company’s June 30, 2025 and March 31, 2025 goodwill impairment testing was performed using the income approach via a discounted cash flow model. The income approach estimates fair value by converting future cash flows to a current amount on the measurement date after taking into consideration marketplace conditions. Assumptions including discount rate and estimated future cash flows had a significant impact to the estimated fair value of the reporting unit. These fair values are Level 3 assets in the fair value hierarchy.
In the event there are further adverse changes in the Company’s projected cash flows or further changes in key assumptions, including but not limited to an increase in the discount rate and further decline in the Company’s stock price, the Company may be required to record additional non-cash impairment charges to goodwill. Such non-cash charges could have a material adverse effect on the Company’s condensed consolidated statements of operations and comprehensive income (loss) and condensed consolidated balance sheets in the reporting period of the charge.
Other intangible assets, net
| June 30, 2025 · December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Intangible Asset | Weighted-Average Amortization Period Remaining (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount |
| Trade names | 15.3 | 17,800 | (833) | 16,967 | 17,800 | $(277) | $17,523 |
| Customer relationships | 2.3 | 4,600 | (1,149) | 3,451 | 4,600 | $(382) | $4,218 |
| Developed technology | 8.5 | 165,100 | (14,198) | 150,902 | 165,100 | $(4,718) | $160,382 |
| Other finite-lived intangible assets | 2.4 | 30 | (5) | 25 | 30 | — | $30 |
| Total intangible assets | $187,530 | $(16,185) | $171,345 | $187,530 | $(5,377) | $182,153 | |
Amortization expense of $5,405 and $10,808 was recognized for the three and six months ended June 30, 2025 (Successor), respectively, and is recorded within Cost of sales, General and administrative and Research and development on the condensed consolidated statements of operations and comprehensive income (loss).
Estimated future amortization expense is as follows:
| Amortization Expense | |
|---|---|
| 2025 (excluding the first six months of fiscal year 2025) | $10,808 |
| 2026 | 21,616 |
| 2027 | 21,234 |
| 2028 | 20,073 |
| 2029 | 18,853 |
| 2030 and thereafter | 78,761 |
| Total | $171,345 |
Note 9. Earnout Shares
As further discussed in our 2024 Annual Report, upon Closing of the Business Combination,5,000,000 “Company Earnout Shares” were contingently issuable and 344,828 “Sponsor Earnout Shares” were issued subject to clawback provisions. The Company Earnout Shares and the Sponsor Earnout Shares are collectively referred to as the “Earnout Shares” and are subject to certain vesting provisions.
On January 7, 2025, a total of 344,828 Sponsor Earnout Shares fully vested and were no longer subject to contingencies as the Company’s public stock price had surpassed $11.50 fortwenty consecutive days, thereby fulfilling the vesting provision for the Sponsor Earnout Shares. These vesting conditions were not effective on the Company Earnout Shares until 6 months following the Business Combination.
On January 8, 2025, the Company’s Board of Directors formally recognized the creation of the Refinity subsidiary, thereby meeting the milestone two conditions for the Company Earnout Shares. As such,2,000,000 shares of Common Stock were issued on February 4, 2025 as a result of the satisfaction of the milestone.
The Earnout Shares related to milestone three are liability classified and were fair valued at $4,370 and $14,752 as of June 30, 2025 and December 31, 2024, respectively. The Company recognized a gain of $3,100 and $9,509 in Change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss) for the three and six months ended June 30, 2025 (Successor), respectively.
Note 10. Warrants
| Number of Public Warrants | Number of Private Warrants | Number of 2024 WTI Warrants | Number of 2025 WTI Warrants | |
|---|---|---|---|---|
| Outstanding, December 31, 2024 (Successor) | 11,240,688 | 7,146,000 | 2 | — |
| Exercised | — | — | — | — |
| Issued | — | — | — | 2 |
| Outstanding, June 30, 2025 (Successor) | 11,240,688 | 7,146,000 | 2 | 2 |
There wereno warrants outstanding during the three and six months ended June 30, 2024 (Predecessor).
Public Warrants
The Company’s equity-classified public warrants expire on October 2, 2029 or earlier upon redemption or liquidation and are exercisable for $11.50 per share.
Private Placement Warrants
The Company’s liability-classified private placement warrants are measured at fair value based on the price of the public warrants (Level 2 fair value measurement). The private placement warrants will expire on October 2, 2029 or earlier upon redemption or liquidation and are exercisable for $11.50 per share. As of June 30, 2025 (Successor) and December 31, 2024 (Predecessor), the fair value of the private placement warrants is $7,146 and $16,793, respectively, and is presented as a current liability in the condensed consolidated balance sheets. For the three and six months ended June 30, 2025 (Successor), the Company recognized a gain of $3,507 and $9,647, respectively, in Change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss).
WTI Warrants
On October 22, 2024, in connection with the WTI Facility, the Company issued warrants (the "2024 WTI Warrants") to the WTI Lenders. The 2024 WTI Warrants are considered freestanding financial instruments and are recorded at fair value on the condensed consolidated balance sheets as a warrant liability in the amount of $12,450 and $17,230 as of June 30, 2025 (Successor) and December 31, 2024 (Predecessor), respectively. For the three and six months ended June 30, 2025 (Successor), the Company recognized a gain of $900 and $4,780, respectively, in change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss). The 2024 WTI Warrants expire on March 31, 2035. See Note 4. Fair Value for details on the valuation.
On April 14, 2025, the Company issued the 2025 WTI Warrants to purchase, at a price of $0.01 per share (subject to certain limitations and adjustment), up to an aggregate total of 495,074 shares of Common Stock, as of the date of issuance and June 30, 2025 (subject to future adjustments to the number and type of shares pursuant to the 2025 WTI Warrants), to the WTI Holders. Each of the 2025 WTI Warrants is exercisable through March 31, 2035, with additional customary rights and protections. The 2025 WTI Warrants were issued to the WTI Holders in conjunction with the first issuance of the Convertible Debentures. The 2025 WTI Warrants serve as consideration for certain provisions under the Consent. The Company recognized the related warrant liability at fair value at an amount of $3,090 at the time of issuance. The 2025 WTI Warrants are recorded at fair value on the condensed consolidated balance sheets in the amount of $3,400 as of June 30, 2025 (Successor). For the three and six months ended June 30, 2025 (Successor), the Company recognized a loss of $310, in the change in fair value of financial liabilities on the condensed consolidated statements of operations and comprehensive income (loss). The 2025 WTI Warrants expire on March 31, 2035. See Note 4. Fair Value for details on the valuation.
Note 11. Stockholders' Equity
For periods prior to the Business Combination on October 2, 2024, the Predecessor had Class B Preferred Units, Class B-1 Preferred Units, Class A Units and Class C Units issued and outstanding. In connection with the Business Combination, the Successor acquired all membership interests that were in existence for the Predecessor.
Preferred Stock
The Company is authorized to issue 25,000,000 shares of preferred stock with a par value of $0.0001 per share.
Series B Preferred Stock
As of June 30, 2025,3,000,000 shares of the authorized preferred stock are designated as Series B preferred stock, $0.0001 par value per share (“Series B Preferred Stock”).
Series B Preferred Stock is entitled to an 8% annual rate dividend. On March 19, 2025, the Company distributed 21,808 shares of Series B Preferred Stock to represent $218 in cumulative dividends for Series B Preferred Stock, covering the period from the initial issue date, as defined in the certificate of designation of Series B Preferred Stock, to December 31, 2024, as a payment in kind at the specified rate. During the three and six months ended June 30, 2025 (Successor), the holders of Series B Preferred Stock exercised their conversion right and converted 1,085,664 shares of Series B Preferred Stock for 2,164,673 shares of Common Stock. Upon conversion, all the converted Series B Preferred Stock shares were canceled and retired.
As a result, the Company had a total of 33,144 shares of Series B Preferred Stock issued and outstanding as of June 30, 2025. As of June 30, 2025, the Company accrued $20 for the 8% dividend in the Obligation to issue equity on the condensed consolidated balance sheets.
Series C Preferred Stock
As of June 30, 2025,5,000,000 shares of the authorized preferred stock are designated as series C preferred stock, $0.0001 par value per share (the “Series C Preferred Stock”). On March 24, 2025, Innventure issued 2,885,848 shares of Series C Preferred Stock at the original issue price for a total amount of $28,858. The consideration received by the Company was in the form of cash, services rendered and the cancellation of related party debt. During the three and six months ended June 30, 2025 (Successor), the holders of Series C Preferred Stock exercised their conversion right and converted 2,735,848 shares of Series C Preferred Stock for 5,471,696 shares of Common Stock. Upon conversion, all the converted Series C Preferred Stock shares were canceled and retired.
The Series C Preferred Stock is subject to similar terms and conditions as the Series B Preferred Stock. The Company had a total of 150,000 shares of Series C Preferred Stock issued and outstanding as of June 30, 2025. As of June 30, 2025, the Company accrued $32 for the 8% dividend in the Obligation to issue equity on the condensed consolidated balance sheets.
Common Stock
The Company is authorized to issue 250,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled toone vote for each share. As of June 30, 2025 there were 55,221,494 shares of Common Stock issued and outstanding.
Standby Equity Purchase Agreement
In October 2023, we entered into the SEPA with Yorkville. This agreement became effective concurrently with the Business Combination.
Pursuant to the SEPA, the Company shall have the right, but not the obligation, to sell to Yorkville up to $75,000 of Common Stock, par value $0.0001 per share, at the Company’s request any time during the commitment period commencing on the Closing and continuing for a term of 3 years.
The SEPA will automatically terminate on the earlier to occur of (i) November 01, 2027 and (ii) the date on which Yorkville shall have made payment of advances pursuant to the SEPA for Common Stock equal to the commitment amount of $75,000.
Pursuant to the SEPA, the Company issued 473,825 shares of Common Stock to the investors as repayments under the Convertible Debentures referenced in Note 5. Borrowings during the three and six months ended June 30, 2025 (Successor).
For the three and six months ended June 30, 2025 (Successor), in addition to the Common Stock issuances pursuant to the SEPA made in repayment towards the Convertible Debentures noted above, the Company soldnil and 73,993 shares of Common Stock under the SEPA, raising $— and $931 in cash proceeds, respectively, which is classified within Issuance of common shares, net of issuance costs in the condensed consolidated statements of changes in mezzanine and stockholders' equity (deficit). As of June 30, 2025, the maximum remaining availability under the SEPA is approximately $70,000.
Service Provider Shares
In December 2023, the Company entered into an agreement to receive financial advisory services in exchange for equity. Upon Closing of the Business Combination, the Company became liable for $441 of Common Stock divided by the conversion price of $10.87, resulting in 40,552 shares. In connection with the closing of the WTI Facility mentioned in Note 5. Borrowings, the Company became liable for $500 worth of Common Stock calculated as the VWAP of the Common Stock over thefive consecutive trading days ending on the trading day immediately preceding November 15, 2024, $11.13, for a total of 44,919 shares. On February 3, 2025, the Company has issued the aggregate 85,471 shares of Common Stock for services rendered.
In October 2023, the Company entered into an agreement to receive financial advisory services in exchange for equity. Upon Closing of the Business Combination, the Company was obligated to pay a success fee in cash in an amount of $600 and equity success fee in $3,000 of Series C Preferred Stock at $10.00 per share. On March 24, 2025, the Company issued the 300,000 shares of Series C Preferred Stock for services rendered.
Note 12. Stock-based Compensation
2024 Equity and Incentive Compensation Plan
Restricted Stock Units
On June 25, 2025, the Company issued 111,525 restricted stock units (“RSUs”) tofive directors pursuant to the Innventure Non-Management Director Compensation Plan . The RSUs had a grant date fair value of $600 based on a fair value per unit of $5.38. The fair value of RSUs is determined based on the closing market price of the Company’s Common Stock at the date of the grant.
During the three and six months ended June 30, 2025 (Successor), the Company recognized compensation costs related to the RSUs of $6,979 and $10,895, respectively, in the condensed consolidated statements of operations and comprehensive income (loss). As of June 30, 2025, the Company had $12,946 in stock-based compensation expense remaining to be recognized over approximately 1.4 years.
Stock Options
On February 26, 2025, the Company issued 140,000 stock options totwo independent contractors. The stock options were granted with an exercise price of $8.84. Using the Black-Scholes option pricing model, the estimated grant date fair value of stock options was $4.97 per option based on an expected volatility of 56%, an expected option term of approximately 5.9 years, and risk-free rate of return of 4.06%. The stock options have a maximum contractual life of 10 years from the grant date.
During the three and six months ended June 30, 2025 (Successor), the Company recognized compensation costs related to the stock options of $1,515 and $2,541, respectively, in the condensed consolidated statements of operations and comprehensive income (loss). As of June 30, 2025, the Company had $4,217 in compensation expense remaining to be recognized over approximately 1.6 years.
Stock Appreciation Rights
In 2024, the Company issued 30,000 cash-settled stock appreciation rights (“SARs”) which were recognized at their fair value as of the date of the grant. These SARs entitle participants to cash equal to the value of the appreciation in Accelsius’ stock price over the base price established of $12.175. These cash-settled SARs are liability classified and are revalued at each reporting period. The SARs were valued as of June 30, 2025 using the Black-Scholes option-pricing model based on an expected volatility of 80%, an expected term of approximately 1.5 years, and risk-free rate of return of 4%. The Company recognized a decrease in compensation expense in the amount of $244 and $693 in relation to the change in fair value of the cash-settled SARs for the three and six months ended June 30, 2025 (Successor), respectively.
On June 25, 2025, the SARs agreements were amended. Under these amendments, any payments by the Company to the participants shall be made in the form of shares of Common Stock and the maximum number of shares of Common Stock that may be issued pursuant to the SAR Agreements shall be 4,000,000.
Subsidiary Equity Plan
Accelsius Subsidiary Equity Plan
During the three and six months ended June 30, 2025 (Successor), there were 133,000 Class C units granted under the Accelsius Subsidiary Equity Plan, with a grant date fair value per share of $20.75. During the three and six months ended June 30, 2024 (Predecessor), there werenil and 110,000 Class C units granted, respectively, with a grant date fair value per unit of $— and $4.41, respectively.
The Company recognized compensation costs related to the Accelsius Subsidiary Equity Plan of $912 and $1,810 for the three and six months ended June 30, 2025 (Successor) and $248 and $593 for the three and six months ended June 30, 2024 (Predecessor), respectively, in the condensed consolidated statements of operations and comprehensive income (loss). As of June 30, 2025, the Company had $8,457 in unit-based compensation expense remaining to be recognized over approximately 2.21 years.
Note 13. Income Taxes
During the three and six months ended June 30, 2025 (Successor), the Company recognized income tax benefits of $2,220 and $3,619, respectively. During the three and six months ended June 30, 2024 (Predecessor), no income tax provision or expense was recorded.
For interim tax reporting, the Company estimated one single effective tax rate for tax jurisdictions not subject to a valuation allowance, which is applied to the year-to-date pre-tax book loss. Tax effects of significant unusual or infrequently occurring items are excluded from the estimated annual effective tax rate calculation and recognized in the interim period in which they occur. The effective tax rate for the three and six months ended June 30, 2025 (Successor) was a benefit of 1.58% and 0.92%, respectively, driven primarily by the impact of the goodwill impairment, which is not deductible for tax purposes.
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are currently assessing its impact on our consolidated financial statements.
Note 14. Net Loss Per Share
The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method requires income available to common shareholders for the period to be allocated between common shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The two-class method also requires losses for the period to be allocated between common shares and participating securities based on their respective rights if the participating security contractually participates in losses. As holders of Series B Preferred Stock, Series C Preferred Stock, 2024 WTI Warrants and 2025 WTI Warrants, which are determined to be participating securities, do not have a contractual obligation to fund losses, undistributed net losses are not allocated to them for purposes of the loss per share calculation.
Given the historical structure of the Predecessor, the Company determined that the calculation of earnings per membership unit results in values that are not a valuable metric to users of these consolidated financial statements. Therefore, earnings per share (“EPS”) information is omitted for the Predecessor periods. Presented in the table below is a reconciliation of the numerator and denominator for the EPS calculations for the three and six months ended June 30, 2025 (Successor):
| Three months ended June 30, 2025 | Six months ended June 30, 2025 | |
|---|---|---|
| Numerator: | ||
| Net loss attributable to Innventure, Inc., shareholders | $(84,227) | $(227,224) |
| Less: Cumulative earnings to participating securities | 37 | 42 |
| Undistributed loss for participating securities | (84,264) | (227,266) |
| Less: Undistributed loss attributable to participating securities | — | — |
| Net loss attributable to common shareholders, basic and diluted | $(84,264) | $(227,266) |
| Denominator: | ||
| Weighted average number of units outstanding, basic and diluted | 52,546,491 | 49,417,092 |
| Net loss per share attributable to common shareholders, basic and diluted | $(1.60) | $(4.60) |
Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive.
The following table presents the potential Common Stock outstanding that was excluded from the computation of diluted net loss per share of Common Stock for the periods presented because including them would have been antidilutive:
| Three months ended June 30, 2025 | Six months ended June 30, 2025 | |
|---|---|---|
| Public warrants | 11,240,688 | 11,240,688 |
| Private placement warrants | 7,146,000 | 7,146,000 |
| 2024 WTI Warrants | 1,000,000 | 1,000,000 |
| Convertible Debentures | 2,817,200 | 2,817,200 |
| 2025 WTI Warrants | 495,074 | 495,074 |
| Series B Preferred Stock | 41,762 | 26,516 |
| Series C Preferred Stock | 189,000 | 194,062 |
| Share options | 1,596,702 | 1,596,702 |
| RSUs | 2,148,001 | 2,148,001 |
| SARs | 320,000 | 320,000 |
Note 15. Related Party Transactions
As more fully described in Note 5. Borrowings, the Company has various notes with affiliates, including short-term notes with three separate related parties which were settled on March 20, 2025. In addition, the Company issued a convertible note to the ESG Fund pursuant to the Amended and Restated Series I Convertible Note Purchase Agreement, dated as of June 2, 2023, by and among Accelsius, ESG Fund, and the other parties thereto, which was converted during the three months ended March 31, 2024. During the three months ended June 30, 2025 (Successor), the Company entered into the Related Party Convertible Notes with various related parties, including other lenders.
Transactions with Directors
As more fully described in Note 12. Stock-based Compensation, the Company issued various equity awards to related parties throughout 2024. On December 9, 2024, the Company issued 1,246,722 RSUs with a grant date fair value of $15,210 and 590,163 stock options with a grant date fair value of $3,913 to a cumulative ofeight directors. On December 31, 2024, the Company issued 200,000 SARs with a grant date fair value of $7,820 tofour directors and former directors. On March 22, 2024, the Company issued 100,000 Class C Units with a grant date fair value of $441 toone director under the Accelsius Subsidiary Equity Plan. Additionally, on June 25, 2025, the Company issued 111,525 RSUs with a grant date fair value of $600 tofive directors pursuant to the Innventure Non-Management Director Compensation Plan.
Transactions with the ESG Fund
As more fully described in Note 2. Accounting Policies in our 2024 Annual Report, the Company earns a 1-2% management fee for administrative, finance and accounting, and other back-office functions from the ESG Fund. Management fees earned from the ESG Fund were $195 and $391 for the three and six months ended June 30, 2025 (Successor), respectively, and $196 and $393 for the three and six months ended June 30, 2024 (Predecessor), respectively, which is recorded as Revenue in the condensed consolidated statements of operations and comprehensive income (loss).
In March 2021, the Company entered into a purchase option agreement with the ESG Fund to sell 145,161 shares of PureCycle Technologies, Inc. (“PCT”) common stock with an exercise price of $1. The option period would have expired on July 22, 2024 and the Company measured the derivative liability at fair value, as further described in Note 4. Fair Value. The option was exercised in March 2022 and the shares are subject to the lock-up provisions. The liability due to the ESG Fund was derecognized as a result of the Business Combination.
Transactions with AeroFlexx
On March 24, 2025, the Company issued 578,294 shares of Series C Preferred Stock to settle AeroFlexx’s debt with a related party. The Company considers the stock issuance to be an investment in AeroFlexx of $5,783 which was recorded in Investments on the condensed consolidated balance sheets.
Note 16. Commitments and Contingencies
PCT Guaranty
On April 22, 2020, the Company entered into a guaranty with a counterparty to unconditionally guarantee PCT’s obligation to reimburse a $5,000 prepayment upon PCT’s failure to meet certain performance thresholds. Performance thresholds include the commission and construction of a plant. The guaranty has no expiration. The total amount paid by the Company under the guaranty is $0 and total interest paid is $0. As of June 30, 2025 (Successor) and December 31, 2024 (Predecessor), there wasno principal outstanding under the guaranty.
Patent Agreement Contingent Fees
In 2022, the Company entered intotwo agreements with an MNC to purchase in-process research and development consisting of patents, technology, and knowledge transfer related to cooling technology for critical electronic equipment in a transaction that was determined to be an asset acquisition.
On June 30, 2025, Accelsius entered into an amended and restated agreement with a certain MNC. The amended agreement modifies several terms and notably (a) eliminates revenue-based royalty payments, (b) extends the due dates for fixed installment payments, (c) modifies and reduces the buy-out fee payable to the MNC in lieu of future installment payments upon certain events such as an assignment of the agreement or a capital event (including a change of control or initial public offering), at the option of either the MNC or Accelsius, and (d) eliminates Accelsius’s ability to unilaterally terminate the agreement upon the occurrence of certain events (other than a material breach) and provides the MNC with certain limited information rights related to the equity ownership of Accelsius.
Under the terms of the agreements, the Company is required to make fixed installment payments, as disclosed below, for each year of the agreement through December 31, 2040.
| Years Ending December 31, | Amount |
|---|---|
| 2025 (excluding the first six months of fiscal year 2025) | $700 |
| 2026 | 825 |
| 2027 | 825 |
| 2028 | 825 |
| 2029 | 825 |
| Thereafter | 9,075 |
| Total | $13,075 |
License and Royalty Commitments
On December 12, 2024, the Company entered into a license agreement with a third party to obtain exclusive rights to use certain know-how, patents, and data relating to processes for the gasification of plastic waste (the “Gasification Technology”). Ownership of the Gasification Technology will transfer to the Company for a fee of $500 contingent upon achievement of a commercial milestone, which is not yet probable.
The Company is committed to pay a semi-annual fee of $65 until ownership transfers or the Gasification Technology is no longer licensed, which is accrued on a monthly basis. During the three and six months ended June 30, 2025 (Successor), $65 and $33, respectively, related to the Gasification Technology was recognized within General and administrative expense in the condensed consolidated statements of operations and comprehensive income (loss).
The Company is committed to pay annual royalties based on Refinity-related gross sales and licensing revenue starting in 2025. For the three and six months ended June 30, 2025 (Successor), no royalty payments were made to the third party.
Framework Agreement
On January 22, 2025, Refinity entered into the Framework Agreement (“Framework Agreement”) with a third party to obtain research services focusing on the further development and optimization of the Gasification Technology.
Refinity agreed to pay a minimum fee of €2,000 for the period beginning January 22, 2025 and ending April 30, 2026 (“Year 1”), and €3,000 for the period beginning May 1, 2026 and ending April 30, 2027 (“Year 2”); provided that, if the third party is unable to provide all of the services contemplated to be provided during Year 1 due to its resource constrains, any unused portion of the minimum fee for Year 1 will be deferred to Year 2 and added to the Year 2 minimum fee. Expenses for services from contracts under the Framework Agreement are recognized as incurred and are applied to the minimum fee. During the three and six months ended June 30, 2025 (Successor), Refinity incurred €425 and €516, respectively, of service expenses toward the Year 1 minimum fee. After currency conversion, Refinity incurred $526 and $619, respectively, toward the Year 1 minimum fee during the three and six months ended June 30, 2025 (Successor). Additionally, during the three and six months ended June 30, 2025 (Successor), Refinity made payments of $302 on costs incurred as a part of the Year 1 minimum fee.
Note 17. Business Segment Data
The Company’s Chief Executive Officer is the Chief Operating Decision Maker (“CODM”) of the Company. The CODM makes operating decisions, allocates resources and assesses performance based on review of historical and potential future product sales, operating expenses, and net income (loss).
Based on the information utilized by the CODM to operate the Company, there isone operating segment and reportable segment, Technology. The Technology segment includes the business activities of Accelsius, a consolidated subsidiary focused on development and manufacture of data center cooling products. Other components of the Company’s consolidated information primarily include operations relating to the original platform business, service activities, Refinity, and equity method investment activities (“Other”).
The following table presents information about the Company’s Technology segment for the three and six months ended June 30, 2025 (Successor) and the three and six months ended June 30, 2024 (Predecessor). The information includes the significant expense categories and amounts regularly provided to the CODM for the reportable segment, which may reflect a different presentation than amounts presented elsewhere in the condensed consolidated financial statements. Inter-segment transactions are not eliminated from segment results when management considers those transactions in assessing the results of the Technology segment.
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Revenue | $254 | $— | $255 | $— |
| Interest income | — | — | 4 | — |
| Cost of sales | $2,861 | $— | $3,045 | $— |
| Employee costs | 3,517 | 2,701 | 7,804 | 5,330 |
| Facilities, equipment & supplies | 80 | 181 | 461 | 399 |
| General and administrative | 840 | 143 | 3,235 | 286 |
| Outside services | 501 | 175 | 809 | 412 |
| Research and development | 3,678 | 690 | 8,023 | 1,343 |
| Sales and marketing | 148 | 194 | 432 | 357 |
| Depreciation expense * | 156 | 64 | 301 | 69 |
| Interest expense | 190 | 55 | 317 | 491 |
| Income tax expense (benefit) | (2,645) | — | (4,104) | — |
| Goodwill impairment | 113,344 | — | 346,557 | — |
| Other ** | 91 | 106 | 195 | 1,750 |
| Total Expenses | $122,761 | $4,309 | $367,075 | $10,437 |
| Net Loss | $(122,507) | $(4,309) | $(366,816) | $(10,437) |
- Represents depreciation expense not already included in Cost of sales.
** Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous expenses.
The following table reconciles the reportable segment to amounts reflected in our condensed consolidated financial statements.
| Three months ended | Six months ended | |||
|---|---|---|---|---|
| June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |
| Revenues: | ||||
| Technology | $254 | $— | $255 | $— |
| Other | 249 | 250 | 499 | 501 |
| Elimination of management services provided to Technology | (27) | (27) | (54) | (54) |
| Consolidated Revenues | $476 | $223 | $700 | $447 |
| Interest Expense: | ||||
| Technology | $190 | $55 | $317 | $491 |
| Other | 2,747 | 44 | 4,382 | 99 |
| Consolidated Interest Expense | $2,937 | $99 | $4,699 | $590 |
| Interest Income: | ||||
| Technology | $— | $— | $4 | $— |
| Other | 290 | 56 | 510 | 142 |
| Consolidated Interest Income | $290 | $56 | $514 | $142 |
| Depreciation and Amortization Expense: | ||||
| Technology | $5,629 | $64 | $11,177 | $69 |
| Other | 5 | — | 5 | — |
| Consolidated Depreciation and Amortization Expense | $5,634 | $64 | $11,182 | $69 |
| Net Loss: | ||||
| Technology | $(122,508) | $(4,309) | $(366,817) | $(10,437) |
| Other | (18,767) | (7,005) | (28,132) | (8,403) |
| Consolidated Net Loss | $(141,275) | $(11,314) | $(394,949) | $(18,840) |
| Capital Expenditures: | ||||
| Technology | $15 | $66 | $932 | $706 |
| Other | — | — | — | — |
| Consolidated Capital Expenditures | $15 | $66 | $932 | $706 |
All long-lived assets are located entirely in the United States. Segment assets are not reviewed by the CODM and therefore are not disclosed.
Note 18. Subsequent Events
In connection with the preparation of the condensed consolidated financial statements and related disclosures for the period ended June 30, 2025, management has evaluated events through August 14, 2025, which is the date the condensed consolidated financial statements were available to be issued. Events occurring after June 30, 2025 are:
In July and August 2025, pursuant to the SEPA, the Company issued a total of 471,812 shares of Common Stock to Yorkville as repayments towards the Convertible Debentures referenced in Note 5. Borrowings. The repayments totaled $2,500, comprised of a principal amount of $2,381 and an $119 payment premium on the Convertible Debentures.
On July 1, 2025, the Company entered into a Term Convertible Note with a related party for a principal amount of $5,000, on substantially the same terms and conditions as the Term Convertible Notes referenced in Note 5. Borrowings, including the maturity and interest rate.
On July 19, 2025, the Company amended and restated the Accelsius Subsidiary Equity Plan. The Class C units available to be issued under the Accelsius Subsidiary Equity Plan was increased to 4,565,000.
On July 21, 2025, the Company authorized the issuance of an additional 915,000 Class C Units under the Accelsius Subsidiary Equity Plan.
In July and August 2025, the Company issued an aggregate 5,000 shares of Common Stock to a third party for services in respect of public relations and investor communications.
On August 12, 2025, Accelsius entered into unsecured convertible promissory notes withtwo parties, for an aggregate principal amount of $2,100. The unsecured convertible promissory notes bear interest at the rate of 6.5% per annum on the principal amount and is repayable on demand by the lenders on or after thetwo-year anniversary of the issuance date. However, the unsecured convertible promissory notes are subordinated in right of payment to the prior payment in full in cash or conversion, as applicable, of the WTI Facility, the Convertible Debentures, the Term Convertible Notes, the Related Party Convertible Notes and the indebtedness of Accelsius owed to Innventure LLC (together, the “Senior Indebtedness”) referenced in Note 5. Borrowings. Although the Company has the right to prepay these notes at any time without premium or penalty, the lenders will not demand repayment, and the Company will not repay the amounts due under these notes as long as any portion of the Senior Indebtedness remains outstanding.
The unsecured convertible promissory notes are automatically convertible, after the first future preferred equity issuance by Accelsius, raising at least $5,000 in gross cash proceeds from unaffiliated investors (the “Next Funding Round”), into the units of the same series sold in the Next Funding Round at a price per unit equal to 80% of the price per unit in such Next Funding Round. Concurrently with the conversion, the Company will issue warrants to the lenders exercisable for Accelsius’ units of the same series sold in the Next Funding Round. These warrants will be exercisable for 0.5 units for every 1 unit that is issued as part of the conversion. The exercise price for the warrants will be set at 120% of the price the units in the Next Funding Round are sold.
On August 14, 2025, the Board approved the accelerated vesting of 46,875 unvested Class C units, which were granted to a related party in 2024 pursuant to the Accelsius Subsidiary Equity Plan. The Company recognized the remaining stock-based compensation expense of $189 based on the acceleration.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.